After the efforts across South Asia, and also in Africa, it has emerged that the pharmaceutical company, Fatro has obtained licenses to market veterinary diclofenac in Italy and Spain where most European vultures occur. This not only threatens vultures in Europe, but also could undermine the progress in Asia, both the principle of it and prospect of leakage of the products and the general veterinary practice of using the killer drug. BirdLife International in Brussels together with The Vulture Conservation Foundation are leading the efforts to counter this through European Union, with support from SAVE and the Vulture Specialist Group, and BirdLife Partners including SEO, LIPU and RSPB.

For more information see the Vulture Conservation Foundation website and the short film there.

Leave a Comment